J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India’s leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.
Financial Results:
J B Chemicals & Pharmaceuticals Ltd reported Revenues for Q1FY25 of ₹1,004.00 Crores up from ₹896.00 Crore year on year, a rise of 12.05%.
Total Expenses for Q1FY25 of ₹771.00 Crores up from ₹707.00 Crores year on year, a rise of 9.05%.
Consolidated Net Profit of ₹177.00 Crores up 24.65% from ₹142.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.39, up 23.94% from ₹9.19 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.